Efficacy of convalescent plasma therapy for COVID-19 in Japan: An open-label, randomized, controlled trial-Reference-Cited by-同舟云学术

Efficacy of convalescent plasma therapy for COVID-19 in Japan: An open-label, randomized, controlled trial

Published:2023-09 Issue:9 Volume:29 Page:869-874
ISSN:1341-321X
Container-title:Journal of Infection and Chemotherapy
language:en
Short-container-title:Journal of Infection and Chemotherapy

Author:

Saito Sho,Kutsuna Satoshi,Akifumi Imamura,Hase Ryota^ORCID,Oda Rentaro^ORCID,Terada Junko,Shimizu Yosuke^ORCID,Uemura Yukari,Takamatsu Yuki,Yasuhara Akemi,Shiratori Katsuyuki,Satake Masahiro^ORCID,Sakamoto Naoya,Miyazaki Yasunari^ORCID,Shimizu Hidefumi,Togano Tomiteru^ORCID,Matsunaga Akihiro^ORCID,Okuma Kazu,Hamaguchi Isao,Fujisawa Kyoko^ORCID,Nagashima Maki,Ashida Shinobu,Terada Mari,Kimura Akiko,Morioka Shinichiro,Matsubayashi Keiji^ORCID,Tsuno Nelson Hirokazu^ORCID,Kojima Makiko,Kuramitsu Madoka,Tezuka Kenta,Ikebe Emi,Ishizaka Yukihito,Kenji Maeda,Hangaishi Akira,Mikami Ayako,Sugiura Wataru,Ohmagari Norio,Mitsuya Hiroaki

Funder

Japan Agency for Medical Research and Development

Government of Japan Ministry of Health Labour and Welfare

Publisher

Elsevier BV

Subject

Infectious Diseases,Pharmacology (medical),Microbiology (medical)

Reference30 articles.

1. Remdesivir for the treatment of Covid-19 – Final report;Beigel;N Engl J Med,2020

2. Dexamethasone in hospitalized patients with Covid-19;Horby;N Engl J Med,2021

3. Baricitinib plus remdesivir for hospitalized adults with Covid-19;Kalil;N Engl J Med,2021

4. Early treatment for Covid-19 with SARS-CoV-2 neutralizing antibody sotrovimab;Gupta;N Engl J Med,2021

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring Study Design Foibles in Randomized Controlled Trials on Convalescent Plasma in Hospitalized COVID-19 Patients;Life;2024-06-22

2. Chinese expert consensus on the management of patients with hematologic malignancies infected with SARS-CoV-2;Journal of Cancer Research and Therapeutics;2023-12